- Tenon Medical published a press release reporting Q4 and full-year 2025 financial results.
- Q4 revenue was USD 1.5 million, up 92%, driven primarily by an increase in surgical procedures in the back half of 2025 across Catamaran and SImmetry+ platforms from adoption by new physician users.
- Q4 gross profit was USD 1 million; gross margin was 69%, up 23 percentage points.
- Full-year revenue was USD 3.9 million, up 20%; full-year gross profit was USD 2.4 million, up 38%.
- Full-year net loss was USD 12.56 million, and Steve Foster said the company entered 2026 with accelerating adoption, improving field productivity and a tightening cost structure.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202603191605ACCESSWRNAPR_____1149724) on March 19, 2026, and is solely responsible for the information contained therein.
Comments